Harald Reinhart - 09 Sep 2021 Form 4 Insider Report for Zai Lab Ltd (ZLAB)

Role
Chief Medical Officer
Signature
/s/ Bruce A. Blefeld, Attorney-in-Fact
Issuer symbol
ZLAB
Transactions as of
09 Sep 2021
Net transactions value
-$1,383,621
Form type
4
Filing time
10 Sep 2021, 16:17:35 UTC
Previous filing
08 Sep 2021
Next filing
27 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZLAB Ordinary Shares Options Exercise $30,000 +10,000 $3.00* 10,000 09 Sep 2021 Direct F1
transaction ZLAB Ordinary Shares Sale $375,212 -2,731 -27% $137.39* 7,269 09 Sep 2021 Direct F1, F2
transaction ZLAB Ordinary Shares Sale $124,497 -900 -12% $138.33* 6,369 09 Sep 2021 Direct F1, F3
transaction ZLAB Ordinary Shares Sale $79,245 -569 -8.9% $139.27* 5,800 09 Sep 2021 Direct F1, F4
transaction ZLAB Ordinary Shares Sale $112,696 -800 -14% $140.87* 5,000 09 Sep 2021 Direct F1, F5
transaction ZLAB Ordinary Shares Sale $99,344 -700 -14% $141.92* 4,300 09 Sep 2021 Direct F1, F6
transaction ZLAB Ordinary Shares Sale $229,344 -1,600 -37% $143.34* 2,700 09 Sep 2021 Direct F1, F7
transaction ZLAB Ordinary Shares Sale $115,480 -800 -30% $144.35* 1,900 09 Sep 2021 Direct F1, F8
transaction ZLAB Ordinary Shares Sale $204,498 -1,400 -74% $146.07* 500 09 Sep 2021 Direct F1, F9
transaction ZLAB Ordinary Shares Sale $73,305 -500 -100% $146.61* 0 09 Sep 2021 Direct F1, F10

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZLAB Stock Options (Right to Buy) Options Exercise $0 -10,000 -43% $0.000000 13,334 09 Sep 2021 Ordinary Shares 10,000 $3.00 Direct F1, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2 Reflects a weighted average sale price of $137.39 per share, at prices ranging from $136.81 to $137.74 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3 Reflects a weighted average sale price of $138.33 per share, at prices ranging from $137.89 to $138.67 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4 Reflects a weighted average sale price of $139.27 per share, at prices ranging from $139.05 to $139.36 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F5 Reflects a weighted average sale price of $140.87 per share, at prices ranging from $140.47 to $141.26 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F6 Reflects a weighted average sale price of $141.92 per share, at prices ranging from $141.47 to $142.30 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F7 Reflects a weighted average sale price of $143.34 per share, at prices ranging from $142.81 to $143.72 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F8 Reflects a weighted average sale price of $144.35 per share, at prices ranging from $144.09 to $144.99 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F9 Reflects a weighted average sale price of $146.07 per share, at prices ranging from $145.49 to $146.46 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F10 Reflects a weighted average sale price of $146.61 per share, at prices ranging from $146.50 to $146.76 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F11 The options vest in equal annual installments over four years beginning on 5/12/2018, the first anniversary of the date of grant.